Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project.

par Monia Ezzalfani, Raphaël Porcher, Alexia Savignoni, Suzette Delaloge, Thomas Filleron, Mathieu Robain, David Pérol, ESME Group
Publié 2021

TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma

par Florie Bertrand, Anne Montfort, Elie Marcheteau, Caroline Imbert, Julia Gilhodes, Thomas Filleron, Philippe Rochaix, Nathalie Andrieu-Abadie, Thierry Levade, Nicolas Meyer, Céline Colacios, Bruno Ségui
Publié 2017

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

par Caroline Imbert, Anne Montfort, Marine Fraisse, Elie Marcheteau, Julia Gilhodes, Elodie Martin, Florie Bertrand, Marlène Marcellin, Odile Burlet-Schiltz, Anne Gonzalez de Peredo, Virginie Garcia, Stéphane Carpentier, Sophie Tartare-Deckert, Pierre Brousset, Philippe Rochaix, Florent Puisset, Thomas Filleron, Nicolas Meyer, Laurence Lamant, Thierry Levade, Bruno Ségui, Nathalie Andrieu-Abadie, Céline Colacios
Publié 2020

Phenotypic discordance between primary and metastatic breast cancer in the large-scale real-life multicenter French ESME cohort

par Thomas Grinda, Natacha Joyon, Amélie Lusque, Sarah Lefèvre, Laurent Arnould, Frédérique Penault-Llorca, Gaëtan Macgrogan, Isabelle Treilleux, Anne Vincent-Salomon, Juliette Haudebourg, Aurélie Maran-Gonzalez, Emmanuelle Charafe-Jauffret, Coralie Courtinard, Camille Franchet, Véronique Verriele, Etienne Brain, Patrick Tas, Cécile Blanc-Fournier, Agnès Leroux, Delphine Loussouarn, Anca Berghian, Eva Brabencova, Jean Pierre Ghnassia, Jean-Yves Scoazec, Suzette Delaloge, Thomas Filleron, Magali Lacroix-Triki
Publié 2021